Bystander-activated T cells could potentially contribute to tumor clearance, either by NKG2D—NKG2D ligand mediated cytotoxicity or by IFNγ-mediated macrophage activation, which has been shown to lead to tumor cell clearance when NK cells were the source of IFNγ45. The gene discussed is KLRK1; the disease is neoplasm.